Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
PHASE2CompletedINTERVENTIONAL
Enrollment
65
Participants
Timeline
Start Date
January 31, 2004
Primary Completion Date
December 31, 2005
Conditions
Hodgkin´s Lymphoma
Interventions
DRUG
Cyclophosphamide
DRUG
Adramycin
DRUG
Procarbacine
DRUG
Prednisone
DRUG
Vincristine
DRUG
Bleomycin
DRUG
Erythropoietin beta
Trial Locations (1)
50931
University of Cologne, Cologne
All Listed Sponsors
lead
University of Cologne
OTHER
NCT00284271 - Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma | Biotech Hunter | Biotech Hunter